Services
Contact
Find us
- RCK Partners,
70 Gracechurch Street,
London,
EC3V 0HR.
© 2024 RCK Partners - Company House No: 12396021
%20(4).png)
The UK's R&D tax credit landscape has changed significantly over the past few years. The introduction of the R&D merged scheme and the Enhanced R&D Intensive Support (ERIS) scheme from April 2024 replaced the long-standing dual system, bringing SMEs and large companies under one framework for the first time. Understanding which scheme applies to your business, and what relief rate you can now claim, is essential to successfully submitting an R&D claim.
This guide walks through the history of the schemes, the current relief rates available, and exactly who qualifies to claim under the merged and ERIS schemes.
For over two decades, UK businesses have claimed R&D tax relief through one of two routes: the SME R&D tax relief scheme or the Research and Development Expenditure Credit (RDEC) scheme. The applicable scheme that a Company had traditionally used was dependent on the size of business from both a turnover and employee threshold.
SME R&D Tax Relief was introduced to help smaller businesses invest in research and development. At its most generous, the relief was worth up to 33% of qualifying R&D expenditure.
From 1 April 2023, the rates were reduced, and capped at a limit of 21.5%. However, businesses that spent at least 40% of their total costs on qualifying R&D remained eligible for an enhanced rate, and could claim up to 27% relief.
RDEC was aimed at large companies, and at SMEs whose R&D activities were subsidised or carried out on behalf of another organisation. It worked differently to the SME scheme: the credit was treated as taxable income ("above the line credit"), making the benefit more visible in reported profits. From April 2023, net benefit increased from 10.5% after tax to up to 16.2% of eligible costs, making the scheme significantly more generous.
From 1 April 2024, HMRC replaced the previous SME/RDEC scheme structure with a single merged R&D scheme, alongside a targeted support route for loss-making R&D-intensive SMEs known as the Enhanced R&D Intensive Support (ERIS) scheme.
The merged R&D scheme is broadly based on the RDEC model, meaning R&D relief is delivered as an above-the-line credit, regardless of company size. This is a significant structural shift for businesses that previously claimed under the SME scheme.
The majority of UK companies undertaking qualifying R&D now claim through the merged scheme.
The ERIS scheme is a higher-rate route for qualifying loss-making SMEs that are heavily investing in R&D, otherwise known as 'R&D intensive.' It was introduced to ensure that innovation-intensive small businesses weren't negatively affected by the move away from the old SME scheme's more generous rates and to provide additional support to these companies.
To access the enhanced R&D intensive support rate, a company must be loss-making and meet an R&D intensity threshold: meaning a significant proportion of their total spend must fall under qualifying R&D activity.
The table below sets out the relief values across the main R&D schemes, as well as the accounting period to which they apply/applied.
The net benefit under the merged scheme depends on the corporation tax rate applicable to your business. At the main 25% corporation tax rate, the next benefit rate is approximately 15%; at the small profits rate of 19%, it is approximately 16.2%.
The shift from SME and RDEC to merged and ERIS has had implications on eligibility as well as rates and benefits. Below are some of the ways eligibility has changed:
Under the old system, being an SME or a large company determined which scheme you fell under, almost automatically (due to employee and turnover thresholds). Under the new system, most companies, whatever their size, will claim under the merged scheme.
Under the old SME scheme, companies could claim even where R&D was undertaken on their behalf (i.e. as a subcontractor). The merged scheme shifts this: the company commissioning the R&D is generally eligible for relief, not the company doing the work.
There was no equivalent to the ERIS intensity threshold under the old SME scheme. Any qualifying SME could access the higher rates regardless of how R&D-heavy their business was. The ERIS scheme is more targeted, offering preferential rates to the SME companies who most need the support.
The merged scheme applies to most UK-incorporated companies that are subject to corporation tax and are carrying out qualifying R&D activities. The key eligibility criteria are:
In terms of previous scheme eligibility, the merged scheme applies to:
To qualify for the Enhanced R&D Intensive Support scheme, a company must meet all of the following conditions:
There’s also a one-year grace period for companies that dip below the 30% intensity threshold. This prevents businesses being moved in and out of the enhanced rate, which would otherwise create significant financial planning challenges for R&D-heavy businesses operating near the boundary. If you’re unsure whether this scheme applies to you, speak to one of our advisors for a free audit of your R&D tax status.
The April 2024 reforms didn't just change the rates, they changed how eligibility works, which costs qualify, and which scheme a business should be claiming under. For companies that have been claiming R&D tax relief for years, the assumption that the same approach will continue to work is one of the more common, and costly mistakes. This is why it’s more important than ever to work with a qualified R&D tax specialist and to seek expert advice.
If you have questions about whether you meet the ERIS intensity threshold, how to identify relevant costs, and which scheme you qualify for, contact one of our specialists for a free audit.
Under the merged R&D scheme, businesses can claim up to ~16% net benefit on qualifying R&D spend depending on how much corporation tax you pay. Under the ERIS scheme, eligible companies can claim a payable credit of 27% of qualifying R&D expenditure.
ERIS stands for Enhanced R&D Intensive Support. It is an enhanced-rate R&D credit route available to loss-making SMEs that spend at least 30% of their total relevant expenditure on qualifying R&D. The ERIS scheme pays a credit of 27%, making it significantly more valuable than the standard rate for those who companies qualify.
The SME R&D tax credit scheme closed to new claims for accounting periods starting on or after 1 April 2024. If your accounting period began before that date, the old SME rules may still apply. For periods starting from April 2024 onwards, you will need to claim under either the merged R&D scheme or the ERIS scheme.
To access ERIS, your company must be an SME (fewer than 500 employees and within the turnover/balance sheet thresholds), be loss-making in the relevant period, and have qualifying R&D costs that represent at least 30% of total relevant expenditure. If you're unsure whether you meet the intensity threshold, contact us for a free audit of your R&D tax status.